In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1832 News Items found
A researcher working in an MSK lab
MSK Research Highlights, December 16, 2025

New MSK research finds a way to package protein-degrading drugs called PROTACs into nanoparticles that target blood vessels within solid tumors; identifies genomic markers that predict whether precancerous blood conditions will turn into multiple myeloma; develops a data-driven approach that could catch lymphedema earlier; and shows that nurse-led palliative care delivered by phone could serve as a scalable model.
microscope image of regulatory T cells
MSK Researchers Solve a Key Colorectal Cancer Mystery

A new MSK study finds that in colorectal cancer, not all regulatory T cells are created equal. One subtype suppresses cancer growth while another aids it. The findings could help improve immunotherapy treatment for the majority of patients with colorectal cancer, and potentially for other cancers.
MSK patient Ellen Coopersmith smiling in a rowboat in Central Park
MSK-Led Research Resulted in 11 New FDA Approvals for Cancer Drugs in 2025

Learn about the clinical trials and research at MSK that led to 11 FDA approvals in 2025, expanding treatment options for a range of different cancers.
Binglong Zhang at work in the lab
Top Cancer Research Advances at MSK in 2025

MSK researchers continued to make strides against cancer in 2025. Learn about some of their top discoveries.
A women sitting in a chair holding a bell
Top Cancer Treatment Advances at MSK in 2025

Learn about some of the most important advances in cancer treatment at MSK in 2025.
In the Clinic
A close-up of fingers inserting acupuncture needles into skin
Acupuncture May Ease ‘Brain Fog’ in Breast Cancer Survivors, Trial Shows

A phase 2 randomized clinical trial at MSK has found that acupuncture can improve cognitive abilities in breast cancer survivors experiencing "brain fog."
Article
MSK hematologist-oncologist Dr. Lia Palomba
FDA Approves Marginal Zone Lymphoma CAR T Cell Treatment

Read about a new CAR T cell therapy now approved for marginal zone lymphoma (MZL).
Article
MSK medical oncologist Komal Jhaveri.
Imlunestrant With or Without Abemaciclib Effective in Treating ER+, HER2- Advanced Breast Cancer That Resists Standard Therapy

Read about a new treatment for people with some ER+, HER2- advanced breast cancers.
MSK medical oncologist and bladder cancer specialist Jonathan Rosenberg
Bladder Cancer Therapy Enfortumab Vedotin (Padcev) Approved by FDA for More Patients

A powerful therapy called an antibody-drug conjugate has been approved by the FDA for more people with bladder cancer.
Article
MSK medical oncologist and breast cancer specialist Dr. Komal Jhaveri.
Antibody-Drug Conjugate for Endocrine-Refractory and Chemotherapy Naive HR+, HER2- Breast Cancer

Read about an antibody-drug conjugate treatment for HR+, HER2- breast cancer.